METRIZAMIDE MYELOGRAPHY IN FIVE DOGS AND TWO CATS WITH SUSPECTED SPINAL CORD NEOPLASMS

Metrizamide myelography was used in five dogs and two cats with signs of spinal cord disease. The history, clinical signs, cerebrospinal fluid examination, and myelography supported a presumptive diagnosis of spinal cord neoplasia in all seven animals. Myelography demonstrated a deviation of the subarachnoid space in each of them. Five of the animals had an expansile intramedullary spinal cord lesion causing thinning and peripheral deviation of the subarachnoid space. Two had extramedullary lesions causing a central deviation of the subarachnoid space. Spinal cord tumors in six of the seven animals were confirmed by necropsy or surgical excision and histopathologic examination. In the seventh animal, a spinal cord fungal grapuloma was diagnosed by necropsy.